Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms (Q38241729)

31 August 2017

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms (English)

1 reference

31 August 2017

0 references

Nanna B Finnerup

2

0 references

Troels Staehelin Jensen

series ordinal

1

object named as

Troels S Jensen

1 reference

31 August 2017

1 September 2014

1 reference

31 August 2017

1 reference

31 August 2017

13

1 reference

31 August 2017

9

1 reference

31 August 2017

924-935

1 reference

A new definition of neuropathic pain

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Translation of symptoms and signs into mechanisms in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Deconstructing the neuropathic pain phenotype to reveal neural mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Central post-stroke pain: clinical characteristics, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pain mechanisms: labeled lines versus convergence in central processing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Hyperesthesia one year after breast augmentation surgery increases the odds for persisting pain at four years A prospective four-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Towards physiologically based treatment of patients with neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neuropathic pain in the general population: a systematic review of epidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The Kyoto protocol of IASP Basic Pain Terminology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

NeuPSIG guidelines on neuropathic pain assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The evidence for pharmacological treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Assessing symptom profiles in neuropathic pain clinical trials: Can it improve outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neuropathic pain: aetiology, symptoms, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

1 reference

7 January 2021

Chapter 34 Classification of neuropathic pain syndromes based on symptoms and signs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

What is spontaneous pain and who has it?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cognitive-emotional sensitization contributes to wind-up-like pain in phantom limb pain patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The mechanism of the pain in trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Persistent postsurgical pain: risk factors and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sensory function and quality of life in patients with multiple sclerosis and pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Phenotypes and predictors of pain following traumatic spinal cord injury: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Clinical, functional and structural determinants of central pain in syringomyelia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Different patterns of hyperalgesia induced by experimental inflammation in human skin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Aftersensations in experimental and clinical hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Dynamic mechanical allodynia in the secondary hyperalgesic area in the capsaicin model—Perceptually similar phenomena as in painful neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Painful neuropathy: altered central processing maintained dynamically by peripheral input

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Myelinated afferents signal the hyperalgesia associated with nerve injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Mechanisms of dynamic mechanical allodynia and dysesthesia in patients with peripheral and central neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Peripheral nociceptor sensitization mediates allodynia in patients with distal symmetric polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Altered C-tactile processing in human dynamic tactile allodynia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Allodynia in patients with post-stroke central pain (CPSP) studied by statistical quantitative sensory testing within individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Quantitative assessment of tactile allodynia in the rat paw

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Dynamic and static components of mechanical hyperalgesia in human hairy skin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sensory symptom profiles and co-morbidities in painful radiculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pain phenomena and possible mechanisms in patients with painful polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cellular and Molecular Mechanisms of Pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sodium channels in normal and pathological pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Central sensitization: a generator of pain hypersensitivity by central neural plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sodium channels and mechanisms of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Hyperpolarization-activated cation channels: from genes to function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Dynamic genotype-selective “phenotypic switching” of CGRP expression contributes to differential neuropathic pain phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Functional MRI study of thalamic and cortical activations evoked by cutaneous heat, cold, and tactile stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Responses of cutaneous A-fiber nociceptors to noxious cold

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Perceptual changes accompanying controlled preferential blocking of A and C fibre responses in intact human skin nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Slowly conducting afferents activated by innocuous low temperature in human skin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Unmyelinated afferents in human skin and their responsiveness to low temperature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Variable threshold of trigeminal cold-thermosensitive neurons is determined by a balance between TRPM8 and Kv1 potassium channels.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Role of TRPM8 and TRPA1 for cold allodynia in patients with cold injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Analgesic treatment of ciguatoxin-induced cold allodynia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

C-nociceptors sensitized to cold in a patient with small-fiber neuropathy and cold allodynia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The thermal grill illusion: unmasking the burn of cold pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Functional imaging of an illusion of pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pharmacological dissection of the paradoxical pain induced by a thermal grill.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Thermosensation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

TRP channels as cellular sensors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

ThermoTRP channels and beyond: mechanisms of temperature sensation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Converting cold into pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Contribution of TRPM8 channels to cold transduction in primary sensory neurons and peripheral nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The molecular and cellular basis of cold sensation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The effect of menthol on cold allodynia in patients with neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pain without nociceptors? Nav1.7-independent pain mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Inhibition of Ca2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sensory abnormalities in consecutive, unselected patients with central post-stroke pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Thermal sensibility changes during ischemic nerve block.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Release of cold-induced burning pain by block of cold-specific afferent input.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Human cutaneous C fibres activated by cooling, heating and menthol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Thermosensory activation of insular cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Peptidergic CGRPα primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Cold hyposensitivity after topical application of capsaicin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

A role for polymodal C-fiber afferents in nonhistaminergic itch

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The capsaicin receptor: a heat-activated ion channel in the pain pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Targeting TRP channels for pain relief

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Peripheral and central mechanisms of cutaneous hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Hyperalgesia with reduced laser evoked potentials in neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The effect of nerve compression and capsaicin on contact heat-evoked potentials related to Aδ- and C-fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Voltage-gated sodium channels: therapeutic targets for pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pathological C-fibres in patients with a chronic painful condition.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-expression and functional inhibition by clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Differential Changes in TRPV1 expression after trigeminal sensory nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Aberrant TRPV1 expression in heat hyperalgesia associated with trigeminal neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Neuropathic pain: emerging treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Ion channel blockers for the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Desipramine relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Safety and efficacy of pregabalin in patients with central post-stroke pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Methadone in post-herpetic neuralgia: A pilot proof-of-concept study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Lamotrigine for central poststroke pain: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Topical lidocaine gel relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Effects of IV morphine in central pain: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Intravenous subhypnotic propofol in central pain: a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Lamotrigine in spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Targeted therapies using electrical and magnetic neural stimulation for the treatment of chronic pain in spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Invasive and non-invasive brain stimulation for treatment of neuropathic pain in patients with spinal cord injury: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Differential recruitment of endogenous pain inhibitory systems in neuropathic pain patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Placebo manipulations reduce hyperalgesia in neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

Combination pharmacotherapy for management of chronic pain: from bench to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970102-4

7 January 2021

10.1016/S1474-4422(14)70102-4

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25142459